Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Use of Deutetrabenazine Reduces Tardive Dyskinesia Severity and Improves Quality of Life: Patient-reported Outcomes in the IMPACT-TD Study

Author:Finkbeiner, Stacy   Konings, Martijn   Henegar, Mark   Klakotskaia, Diana   Yu, Daisy   Jackson, Richard   

Session Name:P7: Movement Disorders: Hyperkinetic Movement Disorders 2  

Topic:Movement Disorders  

Program Number:P7.004  

Author Institution:Teva Branded Pharmaceutical Products R&D LLC, Parsippany, NJ  University of Michigan School of Medicine, Ann Arbor, MI